Wellgistics Health, Inc.: Business Overview, Financials & Competitive Analysis
Wellgistics Health, Inc. scores 3/10 on the AskCyborg Cyborg Score (Weak). Highly speculative micro-cap pharmaceutical distributor with technology aspirations but execution risk and regulatory compliance concerns outweigh growth potential. The company faces significant headwinds including a micro-cap valuation of approximately $34 million, Nasdaq listing compliance deficiency notices with a June 2026 deadline, and recent board member resignations in February 2026.
What is Wellgistics Health, Inc.'s industry? Wellgistics Health, Inc. (wellgistics.com) operates in Pharmaceutical Wholesale Distribution & Healthcare Technology. AskCyborg classifies Wellgistics Health, Inc. under Pharmaceutical Wholesale Distribution & Healthcare Technology in its company registry.
Wellgistics Health (formerly Danam Health) is a pharmaceutical wholesaler and healthcare technology company that distributes generic and branded pharmaceuticals to independent retail pharmacies and manufacturers acros...
Cyborg Score thesis
Highly speculative micro-cap pharmaceutical distributor with technology aspirations but execution risk and regulatory compliance...
Read the full analyst-debate transcript →Get the Latest Wellgistics Health, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeWellgistics Health, Inc. Overview
Pro stress-test →Wellgistics Health (formerly Danam Health) is a pharmaceutical wholesaler and healthcare technology company that distributes generic and branded pharmaceuticals to independent retail pharmacies and manufacturers across the United States. The company operates as a micro health ecosystem integrating wholesale operations, retail specialty pharmacy, and proprietary healthcare technology platforms.
Strategic Profile
Pro stress-test →Wellgistics positions itself at the intersection of physical pharmaceutical distribution and digital healthcare innovation, leveraging platforms like DelivMeds, EinsteinRx AI, and PharmacyChain blockchain technology. The company targets the independent pharmacy network with integrated solutions spanning access, care coordination, dispensing, delivery, and clinical management of pharmaceutical products.
Competitive Landscape
Pro stress-test →Wellgistics competes within pharmaceutical distribution against larger incumbents like Cardinal Health and McKesson, while competing in healthcare technology against platforms like TRxADE (NASDAQ: MEDS). The company differentiates through focus on independent pharmacies and technology integration, though scale disadvantage is significant given $34M market cap versus multi-billion dollar competitors.
Industry Context
Wellgistics Health, Inc. operates in Pharmaceutical Wholesale Distribution & Healthcare Technology.
Key facts
Founded: 2022 · Headquarters: Tampa, Florida · Market cap: $34M